These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5302399)

  • 1. [Treatment of arterial hypertension. Preliminary clinical observations using RO 5-3307 (Declinax)].
    Faria E; Leite PP; de Loyola Buquera LA; Selmi AE; do Amarilho IP; de Freitas AP
    Hospital (Rio J); 1967 Feb; 71(2):476-9. PubMed ID: 5302399
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of Declinax in Nigerian hypertensives.
    Cole TO; Adadevoh BK
    Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary experience with a new postganglion-blocking agent for the management of hypertension.
    Belle MS; Gilmore HR; Keyes MH; Sanford H
    J Fla Med Assoc; 1968 Dec; 55(12):1081-4. PubMed ID: 4881916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arterial hypertension with the prolonged use of Ro 5-3 307].
    Faerchtein I; Roque AF; Cwajg F; Kastansky I; Kac LB
    Rev Bras Med; 1966 Nov; 23(11):790-2. PubMed ID: 5999143
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of DCR-515 in the treatment of arterial hypertension].
    da Cunha GP; Riskala R; Mulinari AS
    Hospital (Rio J); 1968 Dec; 74(6):2061-72. PubMed ID: 4977024
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical study of the antihypertensive effects of debrisoquin sulfate in combination with hydrochlorothiazide.
    Schultz FB
    J Med Assoc State Ala; 1966 Aug; 36(2):147-53. PubMed ID: 5329755
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in venous and arterial tone during treatment with antihypertensive agents.
    Shkhvatsabaya IK; Erina EV; Al'musaui AI
    Cor Vasa; 1977; 19(4-5):310-23. PubMed ID: 598204
    [No Abstract]   [Full Text] [Related]  

  • 9. [New antihypertensive drugs. II. Debrisoquin or Declinax].
    Amery A; Deruyttere M; Fagard R; Koninckx P
    Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prognosis of arterial hypertension and its modification by antihypertensive therapy].
    Holzgreve H
    Internist (Berl); 1981 Mar; 22(3):156-61. PubMed ID: 7012081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the effects of parenteral injection of guanoxan on the arterial blood pressure and kidney function].
    Bréaud P; Ramel C
    Praxis; 1968 Jan; 57(1):24-31. PubMed ID: 5756849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Normalization of arterial pressure in all hypertensive patients: mission impossible?].
    Waeber B
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):42-4. PubMed ID: 9491471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial results in the use of Ro 5-3307 in the treatment of arterial hypertension].
    Faerchtein I; Kastansky I; Pereira CJ; Kac LB; de Brito WF; Roque AF
    Hospital (Rio J); 1965 Sep; 68(3):629-34. PubMed ID: 5322815
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension with neocristepine].
    Liusov VA; Bakhshaliev AB; Kharchenko VI; Savenkov PM; Ibragimov MA
    Sov Med; 1987; (10):65-7. PubMed ID: 3423937
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of apolhlorin on arterial and venous pressure and renal hemodynamics in hypertension].
    Khodzhaev AKh; Lazarenko LI; Maksudkhanov TU; Finkel' AM
    Klin Med (Mosk); 1968 Jan; 46(1):82-6. PubMed ID: 5651401
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sanegyt therapy of moderately severe and severe arterial hypertension].
    Stankusheva G; Elenkova A
    Vutr Boles; 1981; 20(2):81-7. PubMed ID: 7257337
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.